Trials / Completed
CompletedNCT01776047
A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Dong-A Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Study Design : randomized, open label, single-dose, 2-way cross-over design Phase : Phase I
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Exforge® | |
| DRUG | G-0081 |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2013-01-25
- Last updated
- 2013-01-25
Source: ClinicalTrials.gov record NCT01776047. Inclusion in this directory is not an endorsement.